Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Dare Bioscience Inc DARE

Healthcare Biotechnology
Dare Bioscience, Inc. is a biopharmaceutical company. The Company's programs target unmet needs in women's health, primarily in the areas of contraception, sexual health, pelvic pain, fertility, infectious disease, vaginal health and menopause. Its product includes XACIATO (clindamycin phosphate) vaginal gel 2%. XACIATO is a single-dose prescription medication for the treatment of bacterial... see more

Recent & Breaking News (NDAQ:DARE)

9 Stocks Moving In Monday's After-Hours Session

Benzinga.com  February 12, 2018

Daré Bioscience, Inc. to Present at the 2018 BIO CEO & Investor Conference

GlobeNewswire February 6, 2018

Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors

PR Newswire January 10, 2018

Daré Bioscience, Inc. to Present at the LD Micro 10th Annual Main Event Conference

GlobeNewswire December 4, 2017

Daré Bioscience, Inc. to Present at the 2017 BIO Investor Forum

GlobeNewswire October 10, 2017

Daré Bioscience, Inc. to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire September 7, 2017

Daré Bioscience, Inc. to Present at the Liolios 6th Annual Gateway Conference

GlobeNewswire August 30, 2017

Daré Bioscience, Inc. CEO Featured in San Diego Business Journal Article on Women Founders

GlobeNewswire August 15, 2017

Daré Bioscience, Inc. Discusses Key Goals with Wall Street Analyzer

GlobeNewswire August 3, 2017

Daré Bioscience, Inc. announces Memorandum of Understanding with CONRAD for the conduct of the Ovaprene® postcoital test clinical trial

GlobeNewswire July 24, 2017